NMI Holdings (NMIH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

NMI Holdings (NMIH) reported robust Q2 2025 results, with revenue of $173.78 million and EPS of $1.22, exceeding Wall Street consensus estimates by 1.87% and 5.17% respectively. The company also surpassed analyst expectations across key operational metrics, including higher-than-estimated insurance-in-force ($214.65B) and risk-in-force ($57.5B), alongside favorable combined (28.8%), loss (9%), and expense (19.8%) ratios. Despite this strong financial and operational performance, NMIH shares have underperformed, returning -10.4% over the past month against the S&P 500's +3.6% gain.

Analysis

NMI Holdings (NMIH) delivered a robust financial performance for the quarter ended June 2025, exceeding consensus estimates on both revenue and earnings. The company reported revenue of $173.78 million, a 7.2% year-over-year increase and a 1.87% positive surprise, while its EPS of $1.22 represented a 5.17% beat over analyst expectations. This strength was broad-based, with key operational metrics surpassing forecasts. Insurance-in-force grew to $214.65 billion and risk-in-force reached $57.5 billion, both ahead of estimates, indicating healthy underlying business expansion. Profitability metrics were particularly strong, with a combined ratio of 28.8% and a loss ratio of 9.0%, both coming in better than the respective analyst estimates of 30% and 9.1%. This operational outperformance was driven by a 5.6% rise in net premiums earned and a significant 20.6% year-over-year jump in net investment income. Despite these positive fundamental indicators, the company's stock has demonstrated a notable disconnect from its operational results, returning -10.4% over the past month in stark contrast to the S&P 500 composite's +3.6% gain. The current Zacks Rank #3 (Hold) suggests that the market maintains a neutral near-term outlook, despite the strong quarterly report.

Key Decisions for Investors

• The significant divergence between NMIH's strong fundamental performance and its recent -10.4% stock decline warrants investigation into whether the market is pricing in broader macroeconomic risks not reflected in this backward-looking report.
• For investors with a fundamental focus, the across-the-board beat on key insurance metrics, particularly the favorable 28.8% combined ratio, could present a value opportunity if the negative market sentiment proves to be temporary.
• Given the stock's weak momentum and the neutral 'Hold' rating, it may be prudent to wait for signs of a trend reversal before initiating new long positions, as the positive earnings surprise has so far failed to act as a catalyst.